Literature DB >> 26232319

Addressing unmet needs in inflammatory bowel disease.

Bernd Bokemeyer1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26232319     DOI： 10.1016/j.drudis.2015.07.005

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  1 in total

1.  Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.

Authors:  Stefanie Howaldt; Eugeni Domènech; Nicholas Martinez; Carsten Schmidt; Bernd Bokemeyer
Journal:  Inflamm Bowel Dis       Date:  2022-03-02       Impact factor: 5.325
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.